udenafil   Click here for help

GtoPdb Ligand ID: 11577

Synonyms: DA-8159 | DA8159 | Zydena®
Approved drug
udenafil is an approved drug (South Korea)
Compound class: Synthetic organic
Comment: Udenafil (DA-8159) is an oral PDE5 inhibitor that was developed by Dong-A Pharmaceutical Company for erectogenic potential [1,3-4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 130.59
Molecular weight 516.25
XLogP 3.13
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCOc1ccc(cc1c1nc2c(CCC)nn(c2c(=O)[nH]1)C)S(=O)(=O)NCCC1CCCN1C
Isomeric SMILES CCCOc1ccc(cc1c1nc2c(CCC)nn(c2c(=O)[nH]1)C)S(=O)(=O)NCCC1CCCN1C
InChI InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)
InChI Key IYFNEFQTYQPVOC-UHFFFAOYSA-N
References
1. Ahn BO, Kang KK, Ahn GJ, Kwon JW, Kim WB, Kang KS, Lee YS. (2003)
Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury.
Int J Impot Res, 15 (6): 405-11. [PMID:14671658]
2. Doh H, Shin CY, Son M, Ko JI, Yoo M, Kim SH, Kim WB. (2002)
Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.
Arch Pharm Res, 25 (6): 873-8. [PMID:12510841]
3. Oh TY, Kang KK, Ahn BO, Yoo M, Kim WB. (2000)
Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.
Arch Pharm Res, 23 (5): 471-6. [PMID:11059826]
4. Shim HJ, Lee EJ, Kim SH, Kim SH, Yoo M, Kwon JW, Kim WB, Lee HS, Lee MG. (2000)
Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
Res Commun Mol Pathol Pharmacol, 108 (3-4): 275-86. [PMID:11913718]